Reducing stroke risk in dementia patients
A commonly-used treatment for Alzheimer's disease could reduce the risk of stroke among people with dementia.
The Australian-Swedish study, co-authored by Monash University researchers, focussed...
Greater collaboration and funding needed in pharmacy
Greater funding is needed to unite the pharmacy profession with other healthcare professionals. This was the powerful message that came out of PSA’s NSW/ACT...
In case you missed it: our most-read stories of 2020
With the COVID-19 pandemic dominating headlines for much of 2020, it’s no surprise the majority of the most-read Australian Pharmacist stories this year concerned the novel coronavirus.
Non-steroidal care for the treatment and management of mild eczema and...
Dermal Therapy offers a comprehensive range of clinically tested products to treat and manage the symptoms associated with mild eczema and dermatitis.
Schizophrenia
Pharmacists are crucial in supporting people living with schizophrenia through medicine management and strategies to improve health outcomes.
Leading Pharmacy Future: PSA18 highlights
Sydney will become the centre of the Australian pharmacy universe on Friday, as PSA18 brings together more than 1000 pharmacists and healthcare leaders for...













